Jason Hoitt - Jan 18, 2022 Form 4 Insider Report for Provention Bio, Inc. (PRVB)

Role
Chief Commercial Officer
Signature
/s/ Thierry Chauche, as attorney-in-fact
Stock symbol
PRVB
Transactions as of
Jan 18, 2022
Transactions value $
$0
Form type
4
Date filed
1/20/2022, 04:20 PM
Previous filing
May 14, 2021
Next filing
Dec 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVB Stock Option (right to buy) Award $0 +145K $0.00 145K Jan 18, 2022 Common Stock, par value $0.0001 145K $4.39 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest and become exercisable as to 25% on the one-year anniversary of the grant date (January 18, 2023) and the remaining 75% will vest and become exercisable monthly over 36 months such that the options are fully vested and exercisable on the four-year anniversary of the grant date (January 18, 2026).
F2 The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.

Remarks:

Exhibit 24.1 - Power of Attorney